Vascular Biology |
From the Department of Medicine (Cardiac Catheterization Laboratory and Coronary Care Unit, Cardiovascular Division, Brigham and Womens Hospital) Harvard Medical School (F.G.P.W., E.R.E., D.I.S., C.R.), Boston, Mass; the Harvard-M.I.T. Division of Health Sciences and Technology, Massachusetts Institute of Technology (F.G.P.W., E.R.E., C.R.), Cambridge, Mass; the West Roxbury Veterans Affairs Medical Center (F.G.P.W.), West Roxbury, Mass; and the Clinical Investigator Training Program: Harvard-MIT Division of Health Sciences and Technology-Beth Israel Deaconess Medical Center, in collaboration with Pfizer Inc (F.G.P.W.), Groton, Conn.
Correspondence to Frederick G.P. Welt, MD, Harvard-MIT Division of Health Sciences and Technology, MIT, 16-343, Cambridge, MA 02139. E-mail welt{at}mediaone.net
AbstractMacrophages are abundant after stent-induced arterial injury. Inhibition of macrophage recruitment blocks neointimal growth in this model. In contrast, after superficial injury from balloon endothelial denudation, macrophages are sparse. However, many anti-inflammatory therapies remain effective against neointimal growth after balloon injury. To investigate further the role of leukocytes after injury, 41 New Zealand White rabbits underwent iliac artery balloon denudation. In 18, subcutaneous pumps were placed to deliver intravenous heparin (0.3 mg/kg per hour). Arteries were harvested at 6 hours and at 3, 7, and 14 days. In 8 animals, either M1/70 (a monoclonal antibody [mAb] against adhesion molecule Mac-1) or a nonspecific IgG was given (5 mg/kg IV bolus and then 1 mg/kg SC QOD), and arteries were harvested at 6 hours and 3 days. Computer-aided morphometry was performed as was immunohistochemistry to assess smooth muscle cell (SMC) proliferation (bromodeoxyuridine-positive cells), neutrophil content (RPN357, mAb against rabbit neutrophil/thymocyte), and macrophage content (RAM-11, mAb against rabbit macrophage). Heparin inhibited neointimal growth at 7 and 14 days (64% and 32.5% reduction, respectively; P<0.05). Neutrophils were observed in the media early after balloon injury, and heparin and M1/70 inhibited this infiltration (82% and 83% reduction, respectively; P<0.05 each) with a coincident inhibition of medial SMC proliferation at 3 days (49% and 84% reduction, respectively; P<0.05 each). Macrophages were absent at all time points. Neutrophil, but not macrophage, infiltration occurs early after endothelial denudation. Inhibition of this process is associated with a reduction in medial SMC proliferation. These data suggest a central role for neutrophils in restenosis and help to explain prior reports of an inhibitory effect of anti-inflammatory therapies on neointimal growth after balloon injury.
Key Words: neutrophils angioplasty restenosis
This article has been cited by other articles:
![]() |
K. Meguro, H. Iida, H. Takano, T. Morita, M. Sata, R. Nagai, and T. Nakajima Function and role of voltage-gated sodium channel NaV1.7 expressed in aortic smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H211 - H219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, J. M. Sanders, M. H. Bevard, Z. Sun, J. W. Chumley, E. V. Galkina, K. Ley, and I. J. Sarembock CD40 Ligand Promotes Mac-1 Expression, Leukocyte Recruitment, and Neointima Formation after Vascular Injury Am. J. Pathol., April 1, 2008; 172(4): 1141 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inoue, M. Sata, Y. Hikichi, R. Sohma, D. Fukuda, T. Uchida, M. Shimizu, H. Komoda, and K. Node Mobilization of CD34-Positive Bone Marrow-Derived Cells After Coronary Stent Implantation: Impact on Restenosis Circulation, February 6, 2007; 115(5): 553 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sharony, G. Pintucci, P. C. Saunders, E. A. Grossi, F. G. Baumann, A. C. Galloway, and P. Mignatti Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2 Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1651 - H1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Touchard and R. S. Schwartz Preclinical Restenosis Models: Challenges and Successes Toxicol Pathol, January 1, 2006; 34(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, M. Sakuma, Z. Chen, V. Ustinov, C. Shi, K. Croce, A. C. Zago, J. Lopez, P. Andre, E. Plow, et al. Leukocyte Engagement of Platelet Glycoprotein Ib{alpha} via the Integrin Mac-1 Is Critical for the Biological Response to Vascular Injury Circulation, November 8, 2005; 112(19): 2993 - 3000. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H Chong and J. W. Cheng Early Experiences and Clinical Implications of Drug-Eluting Stents: Part 1 Ann. Pharmacother., April 1, 2004; 38(4): 661 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brickson, L. L. Ji, K. Schell, R. Olabisi, B. St. Pierre Schneider, and T. M. Best M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage following stretch injury J Appl Physiol, September 1, 2003; 95(3): 969 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inoue, T. Uchida, I. Yaguchi, Y. Sakai, K. Takayanagi, and S. Morooka Stent-Induced Expression and Activation of the Leukocyte Integrin Mac-1 Is Associated With Neointimal Thickening and Restenosis Circulation, April 8, 2003; 107(13): 1757 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Welt, C. Tso, E. R. Edelman, M. A Kjelsberg, J. F Paolini, P. Seifert, and C. Rogers Leukocyte recruitment and expression of chemokines following different forms of vascular injury Vascular Medicine, February 1, 2003; 8(1): 1 - 7. [Abstract] [PDF] |
||||
![]() |
D. E. Cutlip, M. S. Chauhan, D. S. Baim, K. K. L. Ho, J. J. Popma, J. P. Carrozza, D. J. Cohen, and R. E. Kuntz Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2082 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G.P. Welt and C. Rogers Inflammation and Restenosis in the Stent Era Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1769 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Danenberg, F. G. P. Welt, M. Walker III, P. Seifert, G. S. Toegel, and E. R. Edelman Systemic Inflammation Induced by Lipopolysaccharide Increases Neointimal Formation After Balloon and Stent Injury in Rabbits Circulation, June 18, 2002; 105(24): 2917 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Hwang and E. R. Edelman Arterial Ultrastructure Influences Transport of Locally Delivered Drugs Circ. Res., April 19, 2002; 90(7): 826 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Horvath, F. G.P. Welt, M. Nedelman, P. Rao, and C. Rogers Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted Circ. Res., March 8, 2002; 90(4): 488 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Szocs, B. Lassegue, D. Sorescu, L. L. Hilenski, L. Valppu, T. L. Couse, J. N. Wilcox, M. T. Quinn, J.D. Lambeth, and K. K. Griendling Upregulation of Nox-Based NAD(P)H Oxidases in Restenosis After Carotid Injury Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G.P. Welt, T. C. Woods, and E. R. Edelman Oral Heparin Prevents Neointimal Hyperplasia After Arterial Injury: Inhibitory Potential Depends on Type of Vascular Injury Circulation, December 18, 2001; 104(25): 3121 - 3124. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Horvath, F. G.P. Welt, M. Nedelman, P. Rao, and C. Rogers Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted Circ. Res., March 8, 2002; 90(4): 488 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Hwang and E. R. Edelman Arterial Ultrastructure Influences Transport of Locally Delivered Drugs Circ. Res., April 19, 2002; 90(7): 826 - 832. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |